These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8212839)

  • 1. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.
    Ahrén C; Wennerås C; Holmgren J; Svennerholm AM
    Vaccine; 1993; 11(9):929-34. PubMed ID: 8212839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
    Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.
    Wennerås C; Svennerholm AM; Ahrén C; Czerkinsky C
    Infect Immun; 1992 Jul; 60(7):2605-11. PubMed ID: 1612730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.
    Jertborn M; Ahrén C; Svennerholm AM
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):424-8. PubMed ID: 11238232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes.
    Evans DG; Evans DJ; Opekun AR; Graham DY
    FEMS Microbiol Immunol; 1988 Dec; 1(3):117-25. PubMed ID: 3078739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults.
    Cohen D; Orr N; Haim M; Ashkenazi S; Robin G; Green MS; Ephros M; Sela T; Slepon R; Ashkenazi I; Taylor DN; Svennerholm AM; Eldad A; Shemer J
    Infect Immun; 2000 Aug; 68(8):4492-7. PubMed ID: 10899847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.
    Hall ER; Wierzba TF; Ahrén C; Rao MR; Bassily S; Francis W; Girgis FY; Safwat M; Lee YJ; Svennerholm AM; Clemens JD; Savarino SJ
    Infect Immun; 2001 May; 69(5):2853-7. PubMed ID: 11292698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood.
    Ahrén C; Jertborn M; Svennerholm AM
    Infect Immun; 1998 Jul; 66(7):3311-6. PubMed ID: 9632600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine.
    Jertborn M; Ahrén C; Holmgren J; Svennerholm AM
    Vaccine; 1998; 16(2-3):255-60. PubMed ID: 9607039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
    Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
    J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
    Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
    Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea.
    Rao MR; Wierzba TF; Savarino SJ; Abu-Elyazeed R; El-Ghoreb N; Hall ER; Naficy A; Abdel-Messih I; Frenck RW; Svennerholm AM; Clemens JD
    J Infect Dis; 2005 Feb; 191(4):562-70. PubMed ID: 15655780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children.
    Qadri F; Wennerâs C; Ahmed F; Asaduzzaman M; Saha D; Albert MJ; Sack RB; Svennerholm A
    Vaccine; 2000 Jun; 18(24):2704-12. PubMed ID: 10781858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier.
    Lebens M; Holmgren J
    Dev Biol Stand; 1994; 82():215-27. PubMed ID: 7958476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.
    Tacket CO; Reid RH; Boedeker EC; Losonsky G; Nataro JP; Bhagat H; Edelman R
    Vaccine; 1994 Nov; 12(14):1270-4. PubMed ID: 7856290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia.
    Oyofo BA; Subekti DS; Svennerholm AM; Machpud NN; Tjaniadi P; Komalarini TS; Setiawan B; Campbell JR; Corwin AL; Lesmana M
    Am J Trop Med Hyg; 2001 Aug; 65(2):120-4. PubMed ID: 11508385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.